Zimetbaum Peter, Reynolds Matthew R, Ho Kalon K L, Gaziano Thomas, McDonald Mary Jane, McClennen Seth, Berezin Ronna, Josephson Mark E, Cohen David J
Division of Cardiology, Beth Israel Deaconess Medical Center, One Deaconess Road, Boston, MA 02215, USA.
Am J Cardiol. 2003 Sep 15;92(6):677-81. doi: 10.1016/s0002-9149(03)00821-x.
Health care resource utilization is high for patients presenting with acute atrial fibrillation (AF). The potential for treatment algorithms to safely reduce resource consumption in this setting has not been prospectively evaluated. We designed and implemented a practice guideline for the management of patients presenting to the emergency department (ED) with the primary diagnosis of AF, with emphasis on appropriate cardioversion, use of oral rate-controlling medications, and expedited referral to an outpatient AF clinic. We prospectively collected clinical and resource utilization data on all such patients for 14 months before and after institution of the guideline. Institution of the guideline was associated with a decreased rate of hospital admission (from 74% to 38%), with no differences in ED return visits or hospital readmission within 30 days. No strokes or deaths were observed. This large decrease in resource utilization during the intervention phase of the study translated to an average decrease in 30-day total direct health care costs of approximately $1,400 US dollars per patient. Our clinical and cost outcomes were minimally affected after statistical adjustment for baseline differences between study groups. We conclude that the implementation of our practice guideline was feasible, safe, and effective. Widespread adoption of such practices may have large financial implications for the health care system.
对于急性心房颤动(AF)患者,医疗资源的利用率很高。在这种情况下,治疗算法能否安全降低资源消耗尚未得到前瞻性评估。我们设计并实施了一项针对以AF为主要诊断就诊于急诊科(ED)的患者的管理实践指南,重点在于适当的复律、口服心率控制药物的使用以及快速转诊至门诊房颤诊所。在指南实施前后的14个月内,我们前瞻性地收集了所有此类患者的临床和资源利用数据。指南的实施与住院率降低相关(从74%降至38%),30天内急诊复诊或再次入院情况无差异。未观察到中风或死亡病例。在研究的干预阶段,资源利用率的大幅下降转化为每位患者30天直接医疗总费用平均降低约1400美元。在对研究组之间的基线差异进行统计调整后,我们的临床和成本结果受到的影响最小。我们得出结论,实施我们的实践指南是可行、安全且有效的。广泛采用此类做法可能会对医疗保健系统产生重大财务影响。